These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8237836)
21. Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction. Hockings BE; George T; Mahrous F; Taylor RR; Hajar HA Am J Cardiol; 1987 Nov; 60(13):967-70. PubMed ID: 3673913 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. Manolis AS; Uricchio F; Estes NA Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375 [TBL] [Abstract][Full Text] [Related]
23. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction. Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866 [TBL] [Abstract][Full Text] [Related]
24. Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials. Farré J; Romero J; Rubio JM; Ayala R; Castro-Dorticós J Am J Cardiol; 1999 Mar; 83(5B):55D-63D. PubMed ID: 10089841 [TBL] [Abstract][Full Text] [Related]
25. Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial. Kennedy HL Am J Cardiol; 1997 Nov; 80(9):1208-11. PubMed ID: 9359552 [No Abstract] [Full Text] [Related]
26. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test]. Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120 [TBL] [Abstract][Full Text] [Related]
27. Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity. Mahmarian JJ; Smart FW; Moyé LA; Young JB; Francis MJ; Kingry CL; Verani MS; Pratt CM Am J Cardiol; 1994 Oct; 74(7):681-6. PubMed ID: 7524296 [TBL] [Abstract][Full Text] [Related]
28. [Management of patients with risk of sudden death. The amiodarone example]. Djian J Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868 [TBL] [Abstract][Full Text] [Related]
29. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials. Malik M; Camm AJ Lancet; 1997 Jun; 349(9067):1767-8. PubMed ID: 9193398 [No Abstract] [Full Text] [Related]
31. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone. Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438 [TBL] [Abstract][Full Text] [Related]
32. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164 [TBL] [Abstract][Full Text] [Related]
33. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. McKenna WJ; Oakley CM; Krikler DM; Goodwin JF Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188 [TBL] [Abstract][Full Text] [Related]
34. [Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up]. Di Pede F; Raviele A; Gasparini G; Caprioglio F; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E G Ital Cardiol; 1990 Sep; 20(9):819-27. PubMed ID: 2079183 [TBL] [Abstract][Full Text] [Related]
36. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia]. Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771 [TBL] [Abstract][Full Text] [Related]
37. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218 [TBL] [Abstract][Full Text] [Related]
38. [Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig]. Hottinger S; Mettler D; Leupi F; Gertsch M Schweiz Med Wochenschr; 1985 Nov; 115(45):1594-6. PubMed ID: 4081686 [TBL] [Abstract][Full Text] [Related]
39. [Comparative efficacy of amiodarone and propranolol on ventricular arrhythmia in the post-infarction period]. Fournier C; Brunet M; Kindermans M; Fedorowsky A; Tournadre P; Gensous D; Blondeau M Arch Mal Coeur Vaiss; 1989 Jan; 82(1):69-77. PubMed ID: 2494973 [TBL] [Abstract][Full Text] [Related]
40. Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction. Ozaydín M; Varol E; Dogan A; Aslan SM; Altínbas A Minerva Cardioangiol; 2007 Jun; 55(3):427. PubMed ID: 17534262 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]